𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rasagiline is neuroprotective in a transgenic model of multiple system atrophy

✍ Scribed by Nadia Stefanova; Werner Poewe; Gregor K. Wenning


Book ID
116459265
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
395 KB
Volume
210
Category
Article
ISSN
0014-4886

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Erythropoietin is neuroprotective in a t
✍ Martin KΓΆllensperger; Florian Krismer; Anton Pallua; Nadia Stefanova; Werner Poe πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 441 KB

## Abstract Multiple system atrophy is a rapidly progressive neurodegenerative disorder with a markedly reduced life expectancy. Failure of symptomatic treatment raises an urgent need for disease‐modifying strategies. We have investigated the neuroprotective potential of erythropoietin in (proteoli

In vitro models of multiple system atrop
✍ Nadia Stefanova; Markus Reindl; Werner Poewe; Gregor K. Wenning πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

alpha-Synuclein represents the major constituent of oligodendroglial cytoplasmic inclusions, the hallmark lesion of multiple system atrophy (MSA), a progressive disorder that is associated with selective degenerative cell loss in basal ganglia, cerebellum, brainstem, and spinal cord. The role of abn

In vivo models of multiple system atroph
✍ Pierre-Olivier Fernagut; Imad Ghorayeb; Elsa Diguet; FranΓ§ois Tison πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

Multiple system atrophy (MSA) is a sporadic adult-onset neurodegenerative disorder of unknown etiology clinically characterized by a combination of parkinsonian, pyramidal, and cerebellar signs. Levodopa-unresponsive parkinsonism is present in 80% of MSA cases, and this dominant clinical presentatio